Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TXA2 synthase inhibitors(Thromboxane A2 synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H24ClN3O4 |
InChIKeyGKMKMZGBWNRSSJ-UCXFBLOBSA-N |
CAS Registry142116-37-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Preclinical | GB | 01 Apr 1992 |